Rhodanine hydrolysis leads to potent thioenolate mediated metallo-β-lactamase inhibition
Rhodanine hydrolysis leads to potent thioenolate mediated metallo-β-lactamase inhibition
复制标题
DOI:
10.1038/nchem.2110
复制
发表时间:
2014-12-01
期刊:
影响因子:
21.8
通讯作者:
Schofield, Christopher J.
中科院分区:
文献类型:
--
作者:
Brem, Juergen;van Berkel, Sander S.;Schofield, Christopher J.
The use of beta-lactam antibiotics is compromised by resistance, which is provided by beta-lactamases belonging to both metallo (MBL)- and serine (SBL)-beta-lactamase subfamilies. The rhodanines are one of very few compound classes that inhibit penicillin-binding proteins (PBPs), SBLs and, as recently reported, MBLs. Here, we describe crystallographic analyses of the mechanism of inhibition of the clinically relevant VIM-2 MBL by a rhodanine, which reveal that the rhodanine ring undergoes hydrolysis to give a thioenolate. The thioenolate is found to bind via di-zinc chelation, mimicking the binding of intermediates in beta-lactam hydrolysis. Crystallization of VIM-2 in the presence of the intact rhodanine led to observation of a ternary complex of MBL, a thioenolate fragment and rhodanine. The crystallographic observations are supported by kinetic and biophysical studies, including F-19 NMR analyses, which reveal the rhodanine-derived thioenolate to be a potent broad-spectrum MBL inhibitor and a lead structure for the development of new types of clinically useful MBL inhibitors.